Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • District of Columbia - United States Medical cannabis bill increasing access becomes law…
  • United States - Washington Interstate cannabis trade bill passes Senate and heads to House…
  • South Dakota - United States Governor vetoes industrial hemp revision bill…
  • South Dakota - United States Medical cannabis use prohibited if pregnant or breastfeeding…
  • South Dakota - United States Governor signs bill on medical cannabis qualifying conditions…
  • Oklahoma - United States Medical cannabis-related bill passes Senate…
  • Kentucky - United States Delta-8 THC bill signed by governor and becomes law…
  • Europe EC reveals environmental claims proposal…
  • Spain Parties rally behind Podemos proposal for hemp regulation…
  • Maryland - United States Personal use cannabis good, ‘volume dealing’ bad, House says…
  • North Dakota - United States Legislature approves easier cannabis rules for over-65s in hospices…
  • New Hampshire - United States House backs home growing for medical cannabis patients…
View all
Daily news alerts

New CBD products authorised…

Written by CannIntelligence || 22nd February 2022 || Daily news alerts | Brazil South America

Brazil: The National Public Health Surveillance Agency (Anvisa) has authorised the importation, distribution and sale of three new cannabis-based products: cannabidiol Belcher 150 mg/ml, cannabidiol Aura Pharma 50 mg/ml and cannabidiol Greencare 23.75 mg/ml. The authority has approved 14 cannabis-based products so far. ...

Restricted content. Do you want to read more?

Read our latest free content
Yellow card offence – but comments are a long way from being a dismissal of CBD
Mayhem in Mexico as agency grants firm hemp licence then vows to take it back
Relaxation beats intoxication – IHDC sales aren’t just about getting high
Spannabis: a celebration of the cannabis sector despite lingering uncertainties
Trulieve ends 2022 with over $1bn in revenue, 25 new dispensaries in the US
22nd Century’s cannabinoid division helps the company to double revenue

CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.

© 2023 Tamarind Media Limited (T/A CannIntelligence)
CannIntelligence does not provide legal, strategic or investment advice. Tamarind Media Limited, the publisher of CannIntelligence, does not accept any liability or responsibility for information or views published.